Gingival enlargement, an abnormal growth of the periodontal tissue, is
mainly associated with dental plaque-related inflammation and drug th
erapy. Its true incidence in the general population is unknown. Gingiv
al enlargement produces aesthetic changes, pain, gingival bleeding and
periodontal disorders. Although gingival overgrowth has been traditio
nally recognised as an adverse effect of phenytoin therapy, it has rec
ently been reported in association with the use of cyclosporin and cal
cium antagonists. These 3 classes of drugs produce important changes i
n fibroblast function, which induce an increase in the extracellular m
atrix of the gingival connective tissue. In the majority of those pati
ents for whom dosage reduction, or drug discontinuation or substitutio
n is not possible, and for whom prophylactic measures have failed, sur
gical excision of gingival tissue remains the only treatment of choice
.